OpenEvidence

OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025

OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion.

Source: OpenEvidence, which offers an AI chatbot for doctors, is raising $250M at a $12B valuation, up from $6B in Oct., and has $150M in annualized ad revenue

Stephanie Palazzolo / The Information : X: @steph_palazzolo and @arfurrock X: Stephanie Palazzolo / @steph_palazzolo : New! OpenEvidence, which offers a “ChatGPT for doctors,” is raising at a $12B va...

OpenEvidence, which makes an ad-supported AI chatbot for medical professionals, raised $200M at a $6B valuation, up from $3.5B after a $210M Series B in July

The three-year-old artificial intelligence start-up has drawn investor attention, and money, as its use among doctors, nurses and others skyrockets.

Cambridge, MA-based OpenEvidence, which offers an AI chatbot to help physicians, raised $75M from Sequoia at a $1B valuation, its first outside funding round

AI startup OpenEvidence is raising a fresh round of capital from Sequoia to scale its chatbot for doctors.